Search results for "Intensive Care Medicine"
showing 10 items of 2228 documents
Prevalence of SARS-CoV-2-IgG Antibodies in Children with CKD or Immunosuppression
2021
Coronavirus disease 2019 (COVID-19) rapidly spread from China as a pandemic, with Italy one of the most affected countries worldwide. Unlike adults, children have a milder presentation of COVID-19, even when affected by CKD or on immunosuppressive therapy for glomerulopathies and kidney
El cribado preoperatorio negativo mediante RT-PCR no garantiza la no infección por SARS-CoV-2
2023
Special Issue: "The Latest Clinical Advances in Thrombocytopenia"
2021
Platelets are critical elements in the blood stream, supporting hemostasis as well as performing even more complex tasks within networks of biological (immunity) and pathophysiological processes, such as cancer and ischemia/reperfusion injury [...]
Indications for ECMO: we need to look at the patient first
2021
Mid-term Prognostic Implication of hospitalized COVID-19 patients with Prior Heart Failure diagnosis
2021
Southern Italy: How the Availability of Radiation Therapy, Patient Outcomes, and Risk to Health Care Providers Have Changed During the Coronavirus Di…
2020
The first actions and provisions in a Southern Italy Department of Radiation Oncology are described at the inception of the COVID-19 pandemic.
Clinical utility of novel biosensing platform: Diagnosis of coronavirus SARS-CoV-2 at point of care
2021
Early detection is the first step in the fight against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Therefore, an efficient, rapid, selective, specific, and inexpensive SARS-CoV-2 diagnostic method is the need of the hour. The reverse transcription-polymerase chain reaction (RT-PCR) technology is massively utilized to detect infection with SARS-CoV-2. However, scientists continue to strive to create enhanced technology while continually developing nanomaterial-enabled biosensing methods that can provide new methodologies, potentially fulfilling the present demand for rapid and early identification of coronavirus disease 2019 (COVID-19) patients. Our review presents a summar…
Immunosuppressive treatment for systemic sclerosis—Therapeutic challenges during the COVID ‐19 pandemic
2020
Medical dominos: impact of COVID-19 care on the health of the population
2021
Perspectives for the Treatment of Brucellosis in the 21st Century: The Ioannina Recommendations
2007
Policy Forum. Competing interests: ER has received research grants from Daiichi, Bayer, and Theravance and has served as a consultant to Pfizer, Theravance, Bayer, Wyeth, Rosetta, and BiondVax. Summary Points Brucellosis remains the commonest anthropozoonosis worldwide, and its treatment remains complex, requiring protracted administration of more than one antibiotic. In November 2006, a consensus meeting aimed at reaching a common specialist statement on the treatment of brucellosis was held in Ioannina, Greece under the auspices of the International Society of Chemotherapy and the Institute of Continuing Medical Education of Ioannina. The author panel suggests that the optimal treatment o…